Novavax, Inc. (NVAX) was a big mover last session, as the company saw its shares surge over 13% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 34.3% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions while the Zacks Consensus Estimate of a loss widened over the same period suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
Novavax currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked players in the healthcare industry include Oncolytics Biotech Inc. (ONCY), Medivation, Inc. (MDVN) and Illumina (ILMN) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment